These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15280511)

  • 41. Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.
    Marusic S; Gojo-Tomic N; Bacic-Vrca V; Franic M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):431-3. PubMed ID: 22677303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential interaction involving warfarin and ritonavir.
    Knoell KR; Young TM; Cousins ES
    Ann Pharmacother; 1998 Dec; 32(12):1299-302. PubMed ID: 9876810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telithromycin: the first ketolide antimicrobial.
    Nguyen M; Chung EP
    Clin Ther; 2005 Aug; 27(8):1144-63. PubMed ID: 16199242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
    Schito GC; Marchese A; Elkharrat D; Farrell DJ;
    J Chemother; 2004 Feb; 16(1):13-22. PubMed ID: 15077994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report.
    Sorbera M; Joseph T; DiGregorio RV
    J Pharm Pract; 2017 Oct; 30(5):567-570. PubMed ID: 27543375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
    Hasan SA
    Cornea; 2007 Jul; 26(6):742-3. PubMed ID: 17592328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Macrolides and ketolides].
    Cobos-Trigueros N; Ateka O; Pitart C; Vila J
    Enferm Infecc Microbiol Clin; 2009; 27(7):412-8. PubMed ID: 19625112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).
    Kohno S; Hoban D;
    J Chemother; 2003 Aug; 15(4):335-41. PubMed ID: 12962361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Warfarin-bosentan interaction. Risk of big INR changes].
    Holm L; Jansson A; Noher H
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2248. PubMed ID: 17822204
    [No Abstract]   [Full Text] [Related]  

  • 57. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warfarin dose adjustment required after cannabidiol initiation and titration.
    Cortopassi J
    Am J Health Syst Pharm; 2020 Oct; 77(22):1846-1851. PubMed ID: 33016308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the safety profile of warfarin.
    Chai SJ; Macik BG
    Semin Hematol; 2002 Jul; 39(3):179-86. PubMed ID: 12124680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.